Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul 29:12:972718.
doi: 10.3389/fonc.2022.972718. eCollection 2022.

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics

Tashinga E Bapiro  1 , Rose Hayeshi  2 , Collet Dandara  3   4
Affiliations
Editorial

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics

Tashinga E Bapiro et al. Front Oncol. .
No abstract available

Keywords: anticancer drugs; cytochrome P450; drug metabolism; drug-drug interactions; pharmacodynamics; pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

Author TB was employed by AstraZeneca. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell (2011) 144:646–74. doi: 10.1016/j.cell.2011.02.013 - DOI - PubMed
    1. Grasso C, Jansen G, Giovannetti E. Drug resistance in pancreatic cancer: impact of altered energy metabolism. Crit Rev Oncol/Hematol (2017) 114:139–52. doi: 10.1016/j.critrevonc.2017.03.026 - DOI - PubMed
    1. Cartron G, Blasco H, Paintaud G, Watier H, Le Guellec C. Pharmacokinetics of rituximab and its clinical use: Thought for the best use? Crit Rev Oncol/Hematol (2007) 62:43–52. doi: 10.1016/j.critrevonc.2006.09.004 - DOI - PubMed
    1. Kenmotsu H, Tanigawara Y. Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose. Cancer Sci (2015) 106(5):497–504. doi: 10.1111/cas.12647 - DOI - PMC - PubMed
    1. Mulder TAM, van Eerden RAG, de With M, Elens L, Hesselink DA, Matic M, et al. . CYP3A4∗22 genotyping in clinical practice: Ready for implementation? Front Genet (2021) 12:711943. doi: 10.3389/fgene.2021.711943 - DOI - PMC - PubMed

Publication types

LinkOut - more resources